These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1341443)

  • 1. Treatment of chronic hepatitis C with alpha-interferon.
    Marcellin P
    Eur J Med; 1992; 1(4):194-5. PubMed ID: 1341443
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
    Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
    Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis treated with alpha-interferon].
    Michael M
    Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with interferon alpha of hemophiliacs with chronic hepatitis C].
    Aguilar Franco C; Lucía Cuesta JF; Simón Marco MA
    Rev Clin Esp; 1996 Oct; 196(10):727-8. PubMed ID: 9005483
    [No Abstract]   [Full Text] [Related]  

  • 5. Iron overload and response to alpha-interferon in chronic hepatitis C.
    Girelli CM; Mirata C; Lesinigo E; Casiraghi A
    Am J Gastroenterol; 1995 Jan; 90(1):170-1. PubMed ID: 7695721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of side effects of interferon-alpha in 72 patients treated for chronic active hepatitis C].
    Duché A; Decocq G; Capron-Chivrac D; Andréjak M
    Therapie; 1995; 50(5):419-23. PubMed ID: 8571279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U
    Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
    [No Abstract]   [Full Text] [Related]  

  • 8. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
    Shiell A; Briggs A; Farrell GC
    Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lichen planus during lymphoblastoid interferon treatment for chronic active hepatitis C.
    Fornaciari G; Albertini G; Maccari S; Spacca C
    J Clin Gastroenterol; 1995 Jun; 20(4):346-7. PubMed ID: 7665837
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C].
    Soresi M; Tripi S; Cartabellotta A; di Gaetano G; Carroccio A; Amato S; Migneco G; Montalto G
    Recenti Prog Med; 1996 Apr; 87(4):154-7. PubMed ID: 8643875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of chronic hepatitis B, C and D with alpha-interferon].
    Niederau C
    Fortschr Med; 1993 Feb; 111(6):35-7. PubMed ID: 8462911
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerability and side effects of interferon alpha in the treatment of chronic viral hepatitis].
    Paoletti V; Galeotta G; Mammarella A; Donnarumma L; Labbadia G; De Matteis A; Musca A
    Clin Ter; 1995 May; 146(5):343-9. PubMed ID: 7796566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon therapy of chronic hepatitis C in hemophilia].
    Frickhofen N; Ellbrück D; Seifried E
    Dtsch Med Wochenschr; 1995 Feb; 120(5):157. PubMed ID: 7843037
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 19. Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C.
    Makino Y; Tanaka H; Nakamura K; Fujita M; Akiyama K; Makino I
    J Rheumatol; 1994 Sep; 21(9):1771-2. PubMed ID: 7799367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.